NCT06429137View on ClinicalTrials.gov

A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

May 19, 2025

Study Completion Date

May 27, 2025

Conditions
Healthy
Interventions
DRUG

BI 3731579

BI 3731579

DRUG

Matching placebo to BI 3731579

Matching placebo to BI 3731579

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY